View Document Preview and Link Document Date: 2013-01-29 11:35:07 Open Document File Size: 24,64 KB Share Result on Facebook
City Philadelphia / San Francisco / / Company GeNO LLC / / Event Reorganization / FDA Phase / / Facility American College of Cardiology / American College of Cardiology’s Annual Scientific Session / / IndustryTerm treatment of a multitude of diseases / Hypertension therapies / larger / nasal cannula delivery systems / investigational product / compressed gas / nitric oxide delivery technologies / nitric oxide drug products / cartridge technology / pharmaceutical / combination products / stand-alone medical devices / nitric oxide delivery systems / Treatment of Right Ventricular (RV) Failure / inhaled nitric oxide treatment systems / nitric oxide gas / / MedicalCondition adult pulmonary arterial hypertension / Hypoxemia-induced Pulmonary Hypertension / Idiopathic Pulmonary Fibrosis / mean pulmonary arterial pressure / serious pulmonary and cardiac diseases / pulmonary vascular resistance / potential chronic treatment / expected selective acute pulmonary hemodynamic effects / Pulmonary Hypertension / hypoxemia induced pulmonary hypertension / diseases / hypoxic respiratory failure / acute and chronic Pulmonary Hypertension / persistent pulmonary hypertension / / MedicalTreatment cannula / / Organization FDA office of Combination Products / American College of Cardiology and American Thoracic Society Medical Meetings Waltham / Division of Cardiovascular and Renal Products / U.S. Food and Drug Administration / the American College / American College of Cardiology / / Person David Fine / Robert Roscigno / / Position Executive Vice President of Clinical Development / Chief Executive Officer / / Product MV-1000 nitric oxide delivery system / MV-1000 Inhaled Nitric Oxide / Nitric Oxide / GeNOsyl / MV-1000 / GeNOsyl™ MVG / GeNO / / ProvinceOrState Pennsylvania / California / / Technology nitric oxide delivery technologies / cartridge technology / / URL www.genollc.com / http / SocialTag 
New Pre-Clinical and Clinical Data on GeNO LLC’s Nitric Oxide Delivery Systems to Be Presented at 2013 American College of Cardiology and American Thoracic Society Medical Meetings Waltham, MA (Jan. 29, 2013) – GeNO